CID 9872609

Nastorazepide

Structural Information

Molecular Formula
C29H36N4O5
SMILES
CC(C)(C)C(=O)CN1C2=CC=CC=C2N(C[C@H](C1=O)NC(=O)NC3=CC=CC(=C3)C(=O)O)C4CCCCC4
InChI
InChI=1S/C29H36N4O5/c1-29(2,3)25(34)18-33-24-15-8-7-14-23(24)32(21-12-5-4-6-13-21)17-22(26(33)35)31-28(38)30-20-11-9-10-19(16-20)27(36)37/h7-11,14-16,21-22H,4-6,12-13,17-18H2,1-3H3,(H,36,37)(H2,30,31,38)/t22-/m1/s1
InChIKey
VIJCCFFEBCOOIE-JOCHJYFZSA-N
Compound name
3-[[(3R)-1-cyclohexyl-5-(3,3-dimethyl-2-oxobutyl)-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]carbamoylamino]benzoic acid
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

17
References

198
Patents

520.26855 Da
Monoisotopic Mass

4.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 521.27583 226.7
[M+Na]+ 543.25777 232.2
[M+NH4]+ 538.30237 228.6
[M+K]+ 559.23171 229.5
[M-H]- 519.26127 228.6
[M+Na-2H]- 541.24322 228.5
[M]+ 520.26800 227.5
[M]- 520.26910 227.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe